Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation

Clinical trials sponsored by Gamaleya Research Institute Of Epidemiology And Microbiology, Health Ministry Of The Russian Federation, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New TB vaccine aims to prevent active lung disease in adults Results expected Dec 2026 (estimated)
  • Scientists hunt Tick-Borne germs to unlock disease patterns Results expected Dec 2026 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1
Sort by
  • New TB vaccine aims to prevent active lung disease in adults

    Vaccine Ongoing

    This Phase 3 trial tests the GamTBvac vaccine to prevent active pulmonary tuberculosis in adults aged 18 and older. The study includes people with and without a prior history of TB, comparing the vaccine to a placebo. Researchers will monitor how many participants develop active …

    Phase 3 • Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation • Aim: Vaccine

    Last updated Jul 08, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space